111 related articles for article (PubMed ID: 23208959)
1. In vivo anti-tumour activity of novel Quinazoline derivatives.
Alapati V; Noolvi MN; Manjula SN; Pallavi KJ; Patel HM; Tippeswamy BS; Satyanarayana SV
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(13):1753-64. PubMed ID: 23208959
[TBL] [Abstract][Full Text] [Related]
2. Antitumour activity of Annona muricata L. leaf methanol extracts against Ehrlich Ascites Carcinoma and Dalton's Lymphoma Ascites mediated tumours in Swiss albino mice.
Naik AV; Dessai SN; Sellappan K
Libyan J Med; 2021 Dec; 16(1):1846862. PubMed ID: 33380281
[TBL] [Abstract][Full Text] [Related]
3. Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model.
Dhamija I; Kumar N; Manjula SN; Parihar V; Setty MM; Pai KS
Exp Toxicol Pathol; 2013 Mar; 65(3):235-42. PubMed ID: 21920724
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of the methanolic extract of Ammannia baccifera L. against Dalton's ascites lymphoma induced ascitic and solid tumors in mice.
Loganayaki N; Manian S
J Ethnopharmacol; 2012 Jun; 142(1):305-9. PubMed ID: 22613234
[TBL] [Abstract][Full Text] [Related]
5. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
Ajith TA; Anu V; Riji T
J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
[TBL] [Abstract][Full Text] [Related]
7. The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: involvement of possible antioxidant role.
Bhattacharya S; Haldar PK
J Exp Ther Oncol; 2012; 9(4):281-90. PubMed ID: 22545421
[TBL] [Abstract][Full Text] [Related]
8. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of dimethoxydop-NU as a novel anti-tumor agent.
Mukherjee A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2007 Dec; 26(4):489-97. PubMed ID: 18365543
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
11. Ganoderma lucidum total triterpenes attenuate DLA induced ascites and EAC induced solid tumours in Swiss albino mice.
Smina TP; Mathew J; Janardhanan KK
Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(5):55-9. PubMed ID: 27188870
[TBL] [Abstract][Full Text] [Related]
12. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
13. Antitumor and antioxidant activity of Polyalthia longifolia stem bark ethanol extract.
Manjula SN; Kenganora M; Parihar VK; Kumar S; Nayak PG; Kumar N; Ranganath Pai KS; Rao CM
Pharm Biol; 2010 Jun; 48(6):690-6. PubMed ID: 20645743
[TBL] [Abstract][Full Text] [Related]
14. Antitumour activity of Terminalia arjuna leaf against Ehrlich ascites carcinoma in mice.
Biswas M; Bhattacharya S; Ghosh AK; Kumar RB; Bera S; Gupta M; Haldar PK
Nat Prod Res; 2012; 26(12):1141-4. PubMed ID: 22017259
[TBL] [Abstract][Full Text] [Related]
15. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
Bala A; Kar B; Haldar PK; Mazumder UK; Bera S
J Ethnopharmacol; 2010 May; 129(1):131-4. PubMed ID: 20307641
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antitumor activity of Mimusops elengi leaves on Ehrlich's ascites carcinoma-treated mice.
Kar B; Kumar RB; Bala A; Dolai N; Mazumder UK; Haldar PK
J Diet Suppl; 2012 Sep; 9(3):166-77. PubMed ID: 22891989
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]